APA (7th ed.) Citation

D, P., TH, M., T, S., W, F., E, M., J, R., . . . S, R. (2025). Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma. Bone marrow transplantation, 60(8), 1114. https://doi.org/10.1038/s41409-025-02593-3

Chicago Style (17th ed.) Citation

D, Pan, et al. "Extramedullary Disease but Not Paraskeletal Disease Portends Inferior Outcomes After CAR T Cell Therapy in Multiple Myeloma." Bone Marrow Transplantation 60, no. 8 (2025): 1114. https://doi.org/10.1038/s41409-025-02593-3.

MLA (9th ed.) Citation

D, Pan, et al. "Extramedullary Disease but Not Paraskeletal Disease Portends Inferior Outcomes After CAR T Cell Therapy in Multiple Myeloma." Bone Marrow Transplantation, vol. 60, no. 8, 2025, p. 1114, https://doi.org/10.1038/s41409-025-02593-3.